Tarsus Pharmaceuticals
TARS
#3660
Rank
ยฃ2.61 B
Marketcap
ยฃ61.71
Share price
0.56%
Change (1 day)
55.31%
Change (1 year)

Revenue for Tarsus Pharmaceuticals (TARS)

Revenue in 2025 (TTM): ยฃ0.27 Billion

According to Tarsus Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ0.27 Billion. In 2024 the company made a revenue of ยฃ0.14 Billion an increase over the revenue in the year 2023 that were of ยฃ13.69 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Tarsus Pharmaceuticals from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.27 B89.73%
2024 ยฃ0.14 B964.57%
2023 ยฃ13.69 M-35.82%
2022 ยฃ21.33 M-49.49%
2021 ยฃ42.24 M
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA